Curis (FRA:CUS0) Beginning Cash Position : €25.05 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Curis Beginning Cash Position?

Curis's Beginning Cash Position for the quarter that ended in Mar. 2024 was €25.05 Mil.

Curis's quarterly Beginning Cash Position increased from Sep. 2023 (€19.17 Mil) to Dec. 2023 (€22.94 Mil) and increased from Dec. 2023 (€22.94 Mil) to Mar. 2024 (€25.05 Mil).

Curis's annual Beginning Cash Position declined from Dec. 2021 (€115.43 Mil) to Dec. 2022 (€38.46 Mil) and declined from Dec. 2022 (€38.46 Mil) to Dec. 2023 (€18.61 Mil).

Curis Beginning Cash Position Historical Data

The historical data trend for Curis's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curis Beginning Cash Position Chart

Curis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

21.41

13.48

115.43

38.46

18.61

Curis Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															18.95	29.84	19.17	22.94	25.05

Curis Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Curis Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Curis's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Curis (FRA:CUS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curis Inc (FRA:CUS0) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

CRIS:USA

Address

128 Spring Street, Building C - Suite 500, Lexington, MA, USA, 02421

Website

https://www.curis.com

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Curis (FRA:CUS0) Headlines

No Headlines